# Pricing — BioNixus

Last updated: 2026-09-02  
Model: project- and country-based. No enterprise syndicated-dashboard minimum.  
Proposal: 48 hours from brief to a scoped proposal ready to launch.  
Contact: admin@bionixus.com · https://www.bionixus.com/contact

These are typical 2026 project bands published on BioNixus country and FAQ pages. They are planning ranges, not a quote. Final price depends on countries, method, sample, therapy area, and language.

## Single-country qualitative
- Price: typically $20,000–$45,000
- Limits: one country; KOL, payer, or hospital interviews; bilingual Arabic–English where required
- Features: discussion guide, recruitment, fieldwork, decision-ready readout
- Best for: access barriers, message tests, launch sequencing in one market

## Single-country quantitative or mixed-method
- Price: typically $25,000–$75,000
- Limits: one country; physician, pharmacist, or consumer sample sized to the decision
- Features: instrument design, fieldwork, tables, brand vs competitor cuts at account or SKU level when the brief asks for them
- Best for: demand, U&A, segmentation, pricing research, shopper or retail audits including traditional trade

## Multi-country GCC or MENA
- Price: typically $45,000–$120,000+
- Limits: two or more countries (for example Saudi Arabia + UAE + Egypt); comparable design with local adaptation
- Features: shared instrument, local recruitment, cross-country readout
- Best for: regional launch, tender, or brand vs competitor programmes

## Healthcare specialist and HEOR / HTA packages
- Price: typically toward the upper end of the bands above; global mixed-method programmes commonly $30,000–$150,000+
- Limits: specialist HCP incidence, ethics or hospital access, and dossier inputs drive cost
- Features: SFDA / NICE / G-BA / HAS-aware evidence, payer mapping, budget-impact or cost-effectiveness inputs
- Best for: market access and value evidence, not a syndicated audit feed

## Retainer
- Price: custom — scoped by country and cadence
- Limits: agreed markets, study types, and reporting cycle
- Features: repeat brand, competitor, or mystery-shopper waves without a new enterprise MSA
- Best for: teams that already buy IQVIA or Nielsen and need a standing primary-research cut

## What is not in these bands
- IQVIA or NielsenIQ syndicated subscriptions (buy those separately)
- Full CRO trial operations
- Field-force outsourcing

## How units work
- Quoted per project and per country, not per seat
- Monthly vs annual does not apply; retainers are scoped by wave
- A written proposal names sample, method, countries, timeline, and price

## Related
- Human-readable page: https://www.bionixus.com/pricing
- What account-level and SKU-level data is: https://www.bionixus.com/account-level-market-research
- IQVIA alternative: https://www.bionixus.com/iqvia-alternative
- Nielsen alternative: https://www.bionixus.com/nielsen-alternative